Industry Research Reports
Home > Reports > Medical Devices & Consumables > Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-07-26
Pages: 195 Pages
Report ld: 6982467
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
2025 global deliveries reached approximately 440,000 Brain-computer Interface Systems
Average manufacturer selling price was approximately US$1,900 per delivered system
Non-invasive systems represented the majority of global unit shipments
Medical and research applications concentrated most professional system value
Brain-computer Interface System Market Size(US$)
CAGR 2026-2032
20.4%
Market Size,2032
USD 2,962
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 972 million
Market Forecast in 2032(Value)
US$ 2,962 million
CAGR
20.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Brain-computer Interface System was estimated to be worth US$ 836 million in 2025 and is projected to reach US$ 2962 million, growing at a CAGR of 20.4% from 2026 to 2032.
Brain-computer Interface System refers to an integrated hardware-software system that establishes a direct information pathway between neural activity and computers, assistive devices, rehabilitation equipment, robots, transportation systems or neuromodulation devices. Also referred to as a BCI system or brain-machine interface system, the product normally combines neural-signal electrodes or implantable interfaces, low-noise analog front ends, amplification and digital conversion modules, wired or wireless transmission, real-time preprocessing and neural-decoding software, application management software, and an external control, feedback or stimulation device. The research scope covers non-invasive systems based mainly on EEG, fNIRS or MEG; semi-invasive systems using epidural, cortical-surface or endovascular interfaces; and invasive systems using intracortical penetrating electrodes to capture spikes and local field potentials. Products range from low-channel portable headsets to high-density platforms exceeding 128 channels. Their core functions include neural-state recognition, movement-intention decoding, communication restoration, external-device control, neurofeedback, functional compensation, rehabilitation training and closed-loop neurological treatment. The market focuses on deliverable system-level products with proprietary acquisition hardware, integrated decoding functions and an identifiable interaction or feedback workflow across medical, research, consumer, industrial, transportation and specialized applications.
MARKET TRENDS
The Brain-computer Interface System market is shifting from competition in standalone EEG amplifiers or wearable headsets toward competition in complete neural-interaction architectures. Customers increasingly assess signal-to-noise ratio, synchronization accuracy, motion-artifact suppression, preparation time, decoding latency, cross-session stability, software openness and compatibility with external equipment rather than relying on channel count alone. Non-invasive products are moving toward dry or semi-dry electrodes, wireless acquisition, compact form factors, real-time APIs and multimodal synchronization with eye tracking, EMG, motion capture, stimulation, virtual reality and robotics. Semi-invasive systems are developing along epidural, cortical-surface and endovascular routes that seek a balance between information quality, surgical complexity and long-term stability. Intracortical platforms continue to pursue higher-density neuronal recording for precise cursor, speech and robotic control, but face more demanding implantation, packaging and calibration requirements. The long-term product direction is an adaptive closed loop in which signal acquisition, decoding, device control and sensory or therapeutic feedback are continuously optimized as one system. Commercial differentiation is consequently migrating toward proprietary neural datasets, application-specific workflows, automated calibration, home-use capability and longitudinal performance rather than basic access to raw brain signals.
MARKET SEGMENTATION
By Company
- Neuralink
- OpenBCI
- NeuroPace
- Emotiv
- NeuroSky
- ANT Neuro
- Blackrock Neurotech
- Synchron
- g.tec medical engineering GmbH
- Brain Products
- Bitbrain
- Precision Neuroscience
- Paradromics
- InteraXon
- Neurable
- Mentalab
- mBrainTrain
- Neuroelectrics
- CGX Systems (formerly Cognionics)
- Neurosity
- Wearable Sensing
- Compumedics Neuroscan
- SmartCap(Wenco)
- Shimadzu
- BrainCo
- Neuracle Technology
- CUSOFT
- Deayea
- Entertech
- HNNK
- StairMed
- NeuroXess
- Enlight Medical
- Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
- Hanix
- Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
- Beijing Xinzhida Neural Technology Co., Ltd
- Nanjing Vishee Medical Technology Co., Ltd.
- Xiangyu Medical Co.,Ltd.
- Jiangsu Apon Medical Technology Co.,Ltd.
- Boling Brain Machine (Hangzhou) Technology Co., Ltd.
- Medlander
- Shanghai HeartCare Medical Technology Corporation Limited
- Beijing Chieftain Control Engineering Technology Co., Ltd.
- Kingfar International,Inc.
- Suzhou Nianji Intelligent Technology Co., Ltd.
- Beijing Zhiran Medical Technology Co., Ltd
- Greatthink Medical Technology
- Danyang Huichuang Medical Equipment Co., Ltd.
- OYMotion
- Aura MedTech
- Casibrain
- Gestala
- WE-LINKING
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Non-Invasive
- Partially Invasive
- Invasive
Segment by Application
- Medical Rehabilitation
- Daily Life and Entertainment Consumption
- Industrial Control
- Traffic Driving
- Research & Education
- Military and Others
Segment by Category
- 1 To 8 Channels
- 9 To 32 Channels
- 33 To 128 Channels
- 128 To 256 Channels
Segment by Division
- EEG
- ECoG
- Spikes & LFPs
- fNIRS, MEG and Others
MARKET DYNAMICS
Drivers
Growth is being driven by converging demand from neuroscience research, neurological rehabilitation, functional compensation, assistive communication and closed-loop treatment. Universities and research institutions require configurable systems for neuro-AI, cognitive neuroscience, multimodal experiments and human-machine interaction, while hospitals need products capable of producing measurable clinical or functional outcomes for patients with spinal-cord injury, stroke, epilepsy and severe communication impairment. Improvements in flexible electrodes, low-noise analog front ends, wireless transmission, embedded computing and machine-learning decoding are making systems more portable and usable outside controlled laboratories. Policy and payment infrastructure are also beginning to move in parallel with technology. China’s brain-computer interface industrial policy identifies electrodes, dedicated chips, complete systems, standards and medical, industrial and consumer applications as priority development areas. The National Healthcare Security Administration has established service-price categories for invasive implantation, device removal and non-invasive fitting, while the NMPA approved an implantable hand-function compensation system in March 2026. These developments reduce uncertainty around clinical workflow and create a more defined transition from research projects to regulated product deployment.
Restraints
The principal restraint is the performance gap between laboratory demonstration and reliable daily use. Non-invasive EEG systems are affected by skull attenuation, electrode-contact variation, muscle and eye artefacts, head movement and environmental noise, making decoding accuracy and repeatability highly dependent on the user, task and operating environment. Additional channels may improve spatial coverage but also increase preparation time, calibration complexity, data-processing requirements and operator dependence. Semi-invasive and invasive systems carry substantially higher development and delivery costs related to biocompatible materials, microfabrication, hermetic packaging, sterile production, neurosurgery, clinical trials and long-term follow-up. Endovascular approaches must manage vascular access, anatomical limitations and antithrombotic requirements, while cortical-surface and intracortical systems face infection, tissue response, electrode migration and signal degradation risks. Medical adoption also depends on physician training, hospital capacity, reimbursement and evidence that benefits persist beyond selected clinical-study participants. These limitations create a highly uneven market in which low-cost systems can scale rapidly by volume, while high-value medical systems require long commercialization cycles and significant post-market support.
Opportunities
The most immediate opportunities lie in converting general-purpose neural acquisition platforms into validated systems for defined workflows. Home and community rehabilitation can combine portable EEG hardware, intention decoding, robotic gloves, functional electrical stimulation or exoskeletons with clinician-facing software and remote model updates. Assistive communication products can extend from cursor control to text generation, environmental control and robotic-device operation for patients with paralysis or amyotrophic lateral sclerosis. Closed-loop neurological treatment offers a separate high-value opportunity in which continuous neural monitoring triggers personalized stimulation, with epilepsy providing the most established commercial model. Consumer and enterprise products may integrate brain sensing into headphones, headbands, VR equipment, safety wearables and driver-monitoring systems, provided that measurable benefits justify continued use. Semi-invasive systems may open a clinically relevant middle path between non-invasive accessibility and intracortical information density. China’s approval of an epidural hand-function compensation system, Precision Neuroscience’s FDA-cleared cortical interface, and advancing endovascular and intracortical clinical programs indicate that multiple interface routes can coexist rather than converge on a single dominant architecture.
Challenges
Long-term market development requires technical reliability, clinical evidence, regulatory compliance and sustainable economics to be achieved simultaneously. Neural signals differ materially across users and drift over time, creating persistent challenges in model transfer, recalibration and performance validation. Implantable systems must maintain signal quality while minimizing heat, power consumption, tissue reaction, wireless-transmission failure and replacement risk. The sector also lacks fully harmonized terminology, performance benchmarks, channel-count definitions, data formats and interoperability standards, complicating product comparison and multi-centre validation. Brain data introduces additional requirements around informed consent, cybersecurity, data ownership, mental privacy and the permitted use of neural information. Commercial risk is equally important. Consumer products may show measurable neural-state signals without delivering sufficient recurring utility, while medical companies can generate high product gross margins but still incur substantial clinical, regulatory, physician-training and sales expenses. Scaling therefore depends not only on decoding accuracy but also on standard surgical procedures, application-specific evidence, reimbursement, service capacity and the ability to support patients over extended periods.
INDUSTRY CHAIN ANALYSIS
The upstream Brain-computer Interface System chain consists of wet, dry and semi-dry scalp electrodes; flexible epidural and cortical electrode arrays; penetrating microelectrodes; endovascular electrode structures; conductive and biocompatible materials; hermetic packaging; low-noise amplifiers; analog front-end chips; ADCs; processors; wireless-communication and power modules; batteries; connectors; surgical tools; stimulation modules; and precision mechanical components. Upstream specifications determine signal amplitude, bandwidth, spatial resolution, channel density, noise, power consumption, thermal safety, comfort, implantation difficulty and long-term stability. Non-invasive products place greater emphasis on electrode consistency, ergonomic wearability, rapid setup and resistance to motion artefacts. Implantable products allocate more value and development expenditure to microfabrication, flexible materials, packaging reliability, sterilization, wireless power and surgical compatibility.
Midstream manufacturers integrate the neural interface, acquisition electronics, signal transmission, real-time decoding, application software and external feedback device into a deliverable system. Value creation is concentrated in reproducible signal acquisition, low-latency processing, automated calibration, cross-session model stability, integration with third-party devices and regulatory or clinical validation. Standardized low-channel hardware faces increasing price competition, shifting profit toward software licenses, development tools, validated application modules, consumables and technical services. Research-grade and medical systems retain stronger pricing power because customers require data quality, synchronization, technical support and workflow continuity. Implantable and closed-loop systems can achieve high product margins, but those margins must fund clinical trials, quality systems, regulatory submissions, surgical training and long-term patient management. Downstream customers include universities, hospitals, rehabilitation centres, neurological clinics, assistive-technology providers, consumer-electronics companies, industrial operators, transportation users and specialized government institutions.
SEGMENT INSIGHTS
By interface type, non-invasive systems account for the majority of shipments because they offer lower risk, broader availability and shorter procurement cycles across education, research, consumer interaction and rehabilitation. Semi-invasive systems cover epidural, cortical-surface and endovascular routes that record population-level cortical activity without penetrating neural tissue. These architectures generally offer stronger and more spatially specific signals than scalp EEG while reducing some of the tissue-response risks associated with intracortical arrays. Intracortical systems record spikes and local field potentials and provide the highest potential information density for precise movement, speech and sensory decoding, but their deployment remains constrained by surgical risk, long-term signal stability and high development costs. EEG remains the dominant signal modality by unit volume, while ECoG, spikes and LFPs concentrate high-value clinical and advanced research activity. fNIRS, MEG and multimodal configurations occupy specialized research, cognitive assessment and hybrid-interface niches.
Low-channel 1–8 and 9–32-channel products dominate portable, educational, consumer and rapid-development applications. Systems in the 33–128-channel range serve advanced neuroscience, high-density EEG, brain mapping and complex multimodal experiments, while platforms above 128 channels, including 128–256-channel and higher-density configurations, support detailed cortical recording and advanced implantable research. Price and margin differences between these segments are substantial. Neuracle Technology’s prospectus reported 488 EEG acquisition systems sold in 2025 at an average tax-exclusive price of RMB159,100 per system and a 77.92% gross margin, demonstrating the economics of specialized professional equipment relative to the global weighted average price. Within applications, research and education provide the broadest established customer base, while medical rehabilitation, functional compensation and neurological treatment concentrate higher system value. Daily-life consumption, industrial control and transportation remain earlier-stage markets in which adoption depends on comfort, calibration speed and demonstrable operational benefits.
DOWNSTREAM MARKET OPPORTUNITIES
Downstream demand is becoming more application-specific. Research users require raw-data access, precise event synchronization, configurable channels and compatibility with MATLAB, Python, BCI2000, OpenViBE and multimodal laboratory equipment. Medical customers require repeatable protocols, clinical-grade reliability, therapist or physician interfaces and connectivity with robotic gloves, functional electrical stimulation, wheelchairs, prostheses and neuromodulation equipment. In rehabilitation, the commercial opportunity increasingly combines immediate functional compensation with repeated training intended to promote longer-term recovery. Closed-loop treatment customers place greater emphasis on biomarker detection, stimulation accuracy, longitudinal data and patient-management services. Daily-life and entertainment products require unobtrusive form factors and minimal calibration; industrial and transportation applications require robust state monitoring under motion, vibration and electromagnetic interference. Military and specialized government applications are more likely to focus on training, cognitive-load assessment, fatigue monitoring and complex human-machine interaction. Across these markets, suppliers able to deliver a validated end-to-end workflow rather than a generic signal stream are positioned to capture a larger proportion of downstream value.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains the principal high-value clinical and venture-backed development region. It contains commercially established closed-loop neurological treatment, intracortical clinical programs, endovascular systems and cortical-surface interfaces. NeuroPace provides a commercial benchmark: its RNS System generated US$81.7 million in 2025 revenue with an 81.9% product gross margin. Neuralink is conducting trials for computer and robotic-arm control, Synchron is evaluating an investigational endovascular system, Precision Neuroscience has obtained FDA clearance for its cortical interface, and Paradromics received authorization to initiate a clinical study of its fully implantable system. The region’s advantages include specialist clinical centres, regulatory experience, medical-device financing and access to software and AI capabilities, although development and patient-support costs remain high.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Non-Invasive
Partially Invasive
Invasive
BY APPLICATION，2021-2032(US $ MILLION）
Medical Rehabilitation
Daily Life and Entertainment Consumption
Industrial Control
Traffic Driving
Research & Education
Military and Others
Europe has a strong position in research-grade EEG, neurorehabilitation, multimodal acquisition and open scientific software ecosystems, supported by companies such as g.tec, Brain Products, ANT Neuro, Bitbrain, Mentalab, mBrainTrain and Neuroelectrics. China is developing a broader manufacturing and application base spanning non-invasive research systems, rehabilitation equipment, consumer products and multiple implantable routes. The NMPA approval of an epidural Brain-computer Interface System, the establishment of medical-service price categories and expanding clinical programs have strengthened China’s position in early medical commercialization. Japan retains capabilities in fNIRS, MEG and clinical neurodiagnostic equipment, while South Korea, Taiwan and Southeast Asia remain more concentrated in research institutions, components, clinical collaboration and application development than in globally scaled system brands. Regional competition is therefore differentiated: North America leads high-value clinical innovation, Europe remains strong in research platforms, and China is accelerating full-chain localization and clinical deployment.
COMPETITIVE LANDSCAPE ANALYSIS
The Brain-computer Interface System market has a layered competitive structure. In commercial non-invasive research and development platforms, g.tec, Brain Products, ANT Neuro, OpenBCI, Emotiv, NeuroSky, Bitbrain, Neuroelectrics, Mentalab, mBrainTrain, CGX Systems, Wearable Sensing, Compumedics Neuroscan, Neuracle Technology and BrainCo compete through signal quality, channel density, wireless performance, electrode preparation, synchronization, software openness and global research-channel coverage. InteraXon, Neurable, Neurosity and SmartCap emphasize consumer, enterprise or industrial form factors and applied neural-state interaction. In medical rehabilitation, Chinese suppliers such as BrainCo, Neuracle Technology, CUSOFT, Deayea, Entertech, HNNK, Vishee Medical, Xiangyu Medical, Medlander, Longest and other specialist developers compete through hospital access, rehabilitation-device integration and localized clinical service. The implantable and closed-loop segment is technologically fragmented: Neuralink, Paradromics and Blackrock Neurotech pursue intracortical interfaces; Precision Neuroscience focuses on cortical-surface access; Synchron uses an endovascular route; NeuroPace operates an established responsive neurostimulation business; and Neuracle Technology has commercialized an epidural functional-compensation system in China. StairMed, NeuroXess, Enlight Medical, Xinzhida, Zhirun Medical and other Chinese developers are advancing different implantable architectures and clinical pipelines. Competitive advantage increasingly depends on control of the complete stack—electrodes, acquisition chips, wireless transmission, decoding software, clinical data, regulatory evidence, external devices and long-term service. Scale in low-cost hardware alone is unlikely to establish durable leadership, while companies possessing validated workflows and proprietary longitudinal neural data can sustain stronger pricing and higher entry barriers.
REPORT SCOPE
This report provides a comprehensive view of the global market for Brain-computer Interface System, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Brain-computer Interface System market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Brain-computer Interface System.
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Brain-computer Interface System manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Brain-computer Interface System sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Brain-computer Interface System sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Brain-computer Interface System Product Introduction
1.2 Global Brain-computer Interface System Market Size Forecast
1.2.1 Global Brain-computer Interface System Sales Value (2021–2032)
1.2.2 Global Brain-computer Interface System Sales Volume (2021–2032)
1.2.3 Global Brain-computer Interface System Sales Price (2021–2032)
1.3 Brain-computer Interface System Market Trends & Drivers
1.3.1 Brain-computer Interface System Industry Trends
1.3.2 Brain-computer Interface System Market Drivers & Opportunities
1.3.3 Brain-computer Interface System Market Challenges
1.3.4 Brain-computer Interface System Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Brain-computer Interface System Players Revenue Ranking (2025)
2.2 Global Brain-computer Interface System Revenue by Company (2021–2026)
2.3 Global Brain-computer Interface System Sales Volume Ranking of Players (2025)
2.4 Global Brain-computer Interface System Sales Volume by Company (2021–2026)
2.5 Global Brain-computer Interface System Average Price by Company (2021–2026)
2.6 Key Manufacturers Brain-computer Interface System Manufacturing Base and Headquarters
2.7 Key Manufacturers Brain-computer Interface System Product Offerings
2.8 Key Manufacturers Start of Mass Production of Brain-computer Interface System
2.9 Brain-computer Interface System Market Competitive Analysis
2.9.1 Brain-computer Interface System Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Brain-computer Interface System Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Brain-computer Interface System revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Brain-computer Interface System Market Classification
3.1 Introduction by Type
3.1.1 Non-Invasive
3.1.2 Partially Invasive
3.1.3 Invasive
3.1.4 Global Brain-computer Interface System Sales Value by Type
3.1.4.1 Global Brain-computer Interface System Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Brain-computer Interface System Sales Value, by Type (2021–2032)
3.1.4.3 Global Brain-computer Interface System Sales Value, by Type (%), 2021–2032
3.1.5 Global Brain-computer Interface System Sales Volume by Type
3.1.5.1 Global Brain-computer Interface System Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Brain-computer Interface System Sales Volume, by Type (2021–2032)
3.1.5.3 Global Brain-computer Interface System Sales Volume, by Type (%), 2021–2032
3.1.6 Global Brain-computer Interface System Average Price by Type (2021–2032)
3.2 Introduction by Signal Acquisition Channel Count
3.2.1 1 To 8 Channels
3.2.2 9 To 32 Channels
3.2.3 33 To 128 Channels
3.2.4 128 To 256 Channels
3.2.5 Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count
3.2.5.1 Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count (2021 vs 2025 vs 2032)
3.2.5.2 Global Brain-computer Interface System Sales Value, by Signal Acquisition Channel Count (2021–2032)
3.2.5.3 Global Brain-computer Interface System Sales Value, by Signal Acquisition Channel Count (%), 2021–2032
3.2.6 Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count
3.2.6.1 Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (2021 vs 2025 vs 2032)
3.2.6.2 Global Brain-computer Interface System Sales Volume, by Signal Acquisition Channel Count (2021–2032)
3.2.6.3 Global Brain-computer Interface System Sales Volume, by Signal Acquisition Channel Count (%), 2021–2032
3.2.7 Global Brain-computer Interface System Average Price by Signal Acquisition Channel Count (2021–2032)
3.3 Introduction by Primary Signal Modality
3.3.1 EEG
3.3.2 ECoG
3.3.3 Spikes & LFPs
3.3.4 fNIRS, MEG and Others
3.3.5 Global Brain-computer Interface System Sales Value by Primary Signal Modality
3.3.5.1 Global Brain-computer Interface System Sales Value by Primary Signal Modality (2021 vs 2025 vs 2032)
3.3.5.2 Global Brain-computer Interface System Sales Value, by Primary Signal Modality (2021–2032)
3.3.5.3 Global Brain-computer Interface System Sales Value, by Primary Signal Modality (%), 2021–2032
3.3.6 Global Brain-computer Interface System Sales Volume by Primary Signal Modality
3.3.6.1 Global Brain-computer Interface System Sales Volume by Primary Signal Modality (2021 vs 2025 vs 2032)
3.3.6.2 Global Brain-computer Interface System Sales Volume, by Primary Signal Modality (2021–2032)
3.3.6.3 Global Brain-computer Interface System Sales Volume, by Primary Signal Modality (%), 2021–2032
3.3.7 Global Brain-computer Interface System Average Price by Primary Signal Modality (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Rehabilitation
4.1.2 Daily Life and Entertainment Consumption
4.1.3 Industrial Control
4.1.4 Traffic Driving
4.1.5 Research & Education
4.1.6 Military and Others
4.2 Global Brain-computer Interface System Sales Value by Application
4.2.1 Global Brain-computer Interface System Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Brain-computer Interface System Sales Value, by Application (2021–2032)
4.2.3 Global Brain-computer Interface System Sales Value, by Application (%), 2021–2032
4.3 Global Brain-computer Interface System Sales Volume by Application
4.3.1 Global Brain-computer Interface System Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Brain-computer Interface System Sales Volume, by Application (2021–2032)
4.3.3 Global Brain-computer Interface System Sales Volume, by Application (%), 2021–2032
4.4 Global Brain-computer Interface System Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Brain-computer Interface System Sales Value by Region
5.1.1 Global Brain-computer Interface System Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Brain-computer Interface System Sales Value by Region (2021–2026)
5.1.3 Global Brain-computer Interface System Sales Value by Region (2027–2032)
5.1.4 Global Brain-computer Interface System Sales Value by Region (%), 2021–2032
5.2 Global Brain-computer Interface System Sales Volume by Region
5.2.1 Global Brain-computer Interface System Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Brain-computer Interface System Sales Volume by Region (2021–2026)
5.2.3 Global Brain-computer Interface System Sales Volume by Region (2027–2032)
5.2.4 Global Brain-computer Interface System Sales Volume by Region (%), 2021–2032
5.3 Global Brain-computer Interface System Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Brain-computer Interface System Sales Value, 2021–2032
5.4.2 North America Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Brain-computer Interface System Sales Value, 2021–2032
5.5.2 Europe Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Brain-computer Interface System Sales Value, 2021–2032
5.6.2 Asia Pacific Brain-computer Interface System Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Brain-computer Interface System Sales Value, 2021–2032
5.7.2 South America Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Brain-computer Interface System Sales Value, 2021–2032
5.8.2 Middle East & Africa Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Brain-computer Interface System Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Brain-computer Interface System Sales Value and Sales Volume
6.2.1 Key Countries/Regions Brain-computer Interface System Sales Value, 2021–2032
6.2.2 Key Countries/Regions Brain-computer Interface System Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Brain-computer Interface System Sales Value, 2021–2032
6.3.2 United States Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Brain-computer Interface System Sales Value, 2021–2032
6.4.2 Europe Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Brain-computer Interface System Sales Value, 2021–2032
6.5.2 China Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.5.3 China Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Brain-computer Interface System Sales Value, 2021–2032
6.6.2 Japan Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Brain-computer Interface System Sales Value, 2021–2032
6.7.2 South Korea Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Brain-computer Interface System Sales Value, 2021–2032
6.8.2 Southeast Asia Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Brain-computer Interface System Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Brain-computer Interface System Sales Value, 2021–2032
6.9.2 India Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
6.9.3 India Brain-computer Interface System Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Neuralink
7.1.1 Neuralink Company Information
7.1.2 Neuralink Introduction and Business Overview
7.1.3 Neuralink Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Neuralink Brain-computer Interface System Product Offerings
7.1.5 Neuralink Recent Developments
7.2 OpenBCI
7.2.1 OpenBCI Company Information
7.2.2 OpenBCI Introduction and Business Overview
7.2.3 OpenBCI Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 OpenBCI Brain-computer Interface System Product Offerings
7.2.5 OpenBCI Recent Developments
7.3 NeuroPace
7.3.1 NeuroPace Company Information
7.3.2 NeuroPace Introduction and Business Overview
7.3.3 NeuroPace Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 NeuroPace Brain-computer Interface System Product Offerings
7.3.5 NeuroPace Recent Developments
7.4 Emotiv
7.4.1 Emotiv Company Information
7.4.2 Emotiv Introduction and Business Overview
7.4.3 Emotiv Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Emotiv Brain-computer Interface System Product Offerings
7.4.5 Emotiv Recent Developments
7.5 NeuroSky
7.5.1 NeuroSky Company Information
7.5.2 NeuroSky Introduction and Business Overview
7.5.3 NeuroSky Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 NeuroSky Brain-computer Interface System Product Offerings
7.5.5 NeuroSky Recent Developments
7.6 ANT Neuro
7.6.1 ANT Neuro Company Information
7.6.2 ANT Neuro Introduction and Business Overview
7.6.3 ANT Neuro Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 ANT Neuro Brain-computer Interface System Product Offerings
7.6.5 ANT Neuro Recent Developments
7.7 Blackrock Neurotech
7.7.1 Blackrock Neurotech Company Information
7.7.2 Blackrock Neurotech Introduction and Business Overview
7.7.3 Blackrock Neurotech Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Blackrock Neurotech Brain-computer Interface System Product Offerings
7.7.5 Blackrock Neurotech Recent Developments
7.8 Synchron
7.8.1 Synchron Company Information
7.8.2 Synchron Introduction and Business Overview
7.8.3 Synchron Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Synchron Brain-computer Interface System Product Offerings
7.8.5 Synchron Recent Developments
7.9 g.tec medical engineering GmbH
7.9.1 g.tec medical engineering GmbH Company Information
7.9.2 g.tec medical engineering GmbH Introduction and Business Overview
7.9.3 g.tec medical engineering GmbH Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 g.tec medical engineering GmbH Brain-computer Interface System Product Offerings
7.9.5 g.tec medical engineering GmbH Recent Developments
7.10 Brain Products
7.10.1 Brain Products Company Information
7.10.2 Brain Products Introduction and Business Overview
7.10.3 Brain Products Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Brain Products Brain-computer Interface System Product Offerings
7.10.5 Brain Products Recent Developments
7.11 Bitbrain
7.11.1 Bitbrain Company Information
7.11.2 Bitbrain Introduction and Business Overview
7.11.3 Bitbrain Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Bitbrain Brain-computer Interface System Product Offerings
7.11.5 Bitbrain Recent Developments
7.12 Precision Neuroscience
7.12.1 Precision Neuroscience Company Information
7.12.2 Precision Neuroscience Introduction and Business Overview
7.12.3 Precision Neuroscience Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Precision Neuroscience Brain-computer Interface System Product Offerings
7.12.5 Precision Neuroscience Recent Developments
7.13 Paradromics
7.13.1 Paradromics Company Information
7.13.2 Paradromics Introduction and Business Overview
7.13.3 Paradromics Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Paradromics Brain-computer Interface System Product Offerings
7.13.5 Paradromics Recent Developments
7.14 InteraXon
7.14.1 InteraXon Company Information
7.14.2 InteraXon Introduction and Business Overview
7.14.3 InteraXon Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 InteraXon Brain-computer Interface System Product Offerings
7.14.5 InteraXon Recent Developments
7.15 Neurable
7.15.1 Neurable Company Information
7.15.2 Neurable Introduction and Business Overview
7.15.3 Neurable Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Neurable Brain-computer Interface System Product Offerings
7.15.5 Neurable Recent Developments
7.16 Mentalab
7.16.1 Mentalab Company Information
7.16.2 Mentalab Introduction and Business Overview
7.16.3 Mentalab Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Mentalab Brain-computer Interface System Product Offerings
7.16.5 Mentalab Recent Developments
7.17 mBrainTrain
7.17.1 mBrainTrain Company Information
7.17.2 mBrainTrain Introduction and Business Overview
7.17.3 mBrainTrain Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 mBrainTrain Brain-computer Interface System Product Offerings
7.17.5 mBrainTrain Recent Developments
7.18 Neuroelectrics
7.18.1 Neuroelectrics Company Information
7.18.2 Neuroelectrics Introduction and Business Overview
7.18.3 Neuroelectrics Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Neuroelectrics Brain-computer Interface System Product Offerings
7.18.5 Neuroelectrics Recent Developments
7.19 CGX Systems (formerly Cognionics)
7.19.1 CGX Systems (formerly Cognionics) Company Information
7.19.2 CGX Systems (formerly Cognionics) Introduction and Business Overview
7.19.3 CGX Systems (formerly Cognionics) Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 CGX Systems (formerly Cognionics) Brain-computer Interface System Product Offerings
7.19.5 CGX Systems (formerly Cognionics) Recent Developments
7.20 Neurosity
7.20.1 Neurosity Company Information
7.20.2 Neurosity Introduction and Business Overview
7.20.3 Neurosity Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Neurosity Brain-computer Interface System Product Offerings
7.20.5 Neurosity Recent Developments
7.21 Wearable Sensing
7.21.1 Wearable Sensing Company Information
7.21.2 Wearable Sensing Introduction and Business Overview
7.21.3 Wearable Sensing Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Wearable Sensing Brain-computer Interface System Product Offerings
7.21.5 Wearable Sensing Recent Developments
7.22 Compumedics Neuroscan
7.22.1 Compumedics Neuroscan Company Information
7.22.2 Compumedics Neuroscan Introduction and Business Overview
7.22.3 Compumedics Neuroscan Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 Compumedics Neuroscan Brain-computer Interface System Product Offerings
7.22.5 Compumedics Neuroscan Recent Developments
7.23 SmartCap(Wenco)
7.23.1 SmartCap(Wenco) Company Information
7.23.2 SmartCap(Wenco) Introduction and Business Overview
7.23.3 SmartCap(Wenco) Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.23.4 SmartCap(Wenco) Brain-computer Interface System Product Offerings
7.23.5 SmartCap(Wenco) Recent Developments
7.24 Shimadzu
7.24.1 Shimadzu Company Information
7.24.2 Shimadzu Introduction and Business Overview
7.24.3 Shimadzu Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.24.4 Shimadzu Brain-computer Interface System Product Offerings
7.24.5 Shimadzu Recent Developments
7.25 BrainCo
7.25.1 BrainCo Company Information
7.25.2 BrainCo Introduction and Business Overview
7.25.3 BrainCo Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.25.4 BrainCo Brain-computer Interface System Product Offerings
7.25.5 BrainCo Recent Developments
7.26 Neuracle Technology
7.26.1 Neuracle Technology Company Information
7.26.2 Neuracle Technology Introduction and Business Overview
7.26.3 Neuracle Technology Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.26.4 Neuracle Technology Brain-computer Interface System Product Offerings
7.26.5 Neuracle Technology Recent Developments
7.27 CUSOFT
7.27.1 CUSOFT Company Information
7.27.2 CUSOFT Introduction and Business Overview
7.27.3 CUSOFT Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.27.4 CUSOFT Brain-computer Interface System Product Offerings
7.27.5 CUSOFT Recent Developments
7.28 Deayea
7.28.1 Deayea Company Information
7.28.2 Deayea Introduction and Business Overview
7.28.3 Deayea Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.28.4 Deayea Brain-computer Interface System Product Offerings
7.28.5 Deayea Recent Developments
7.29 Entertech
7.29.1 Entertech Company Information
7.29.2 Entertech Introduction and Business Overview
7.29.3 Entertech Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.29.4 Entertech Brain-computer Interface System Product Offerings
7.29.5 Entertech Recent Developments
7.30 HNNK
7.30.1 HNNK Company Information
7.30.2 HNNK Introduction and Business Overview
7.30.3 HNNK Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.30.4 HNNK Brain-computer Interface System Product Offerings
7.30.5 HNNK Recent Developments
7.31 StairMed
7.31.1 StairMed Company Information
7.31.2 StairMed Introduction and Business Overview
7.31.3 StairMed Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.31.4 StairMed Brain-computer Interface System Product Offerings
7.31.5 StairMed Recent Developments
7.32 NeuroXess
7.32.1 NeuroXess Company Information
7.32.2 NeuroXess Introduction and Business Overview
7.32.3 NeuroXess Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.32.4 NeuroXess Brain-computer Interface System Product Offerings
7.32.5 NeuroXess Recent Developments
7.33 Enlight Medical
7.33.1 Enlight Medical Company Information
7.33.2 Enlight Medical Introduction and Business Overview
7.33.3 Enlight Medical Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.33.4 Enlight Medical Brain-computer Interface System Product Offerings
7.33.5 Enlight Medical Recent Developments
7.34 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd.
7.34.1 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
7.34.2 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Introduction and Business Overview
7.34.3 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.34.4 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Offerings
7.34.5 Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments
7.35 Hanix
7.35.1 Hanix Company Information
7.35.2 Hanix Introduction and Business Overview
7.35.3 Hanix Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.35.4 Hanix Brain-computer Interface System Product Offerings
7.35.5 Hanix Recent Developments
7.36 Zhongdian Yunnao (Tianjin) Technology Co., Ltd.
7.36.1 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
7.36.2 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Introduction and Business Overview
7.36.3 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.36.4 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Offerings
7.36.5 Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments
7.37 Beijing Xinzhida Neural Technology Co., Ltd
7.37.1 Beijing Xinzhida Neural Technology Co., Ltd Company Information
7.37.2 Beijing Xinzhida Neural Technology Co., Ltd Introduction and Business Overview
7.37.3 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.37.4 Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Offerings
7.37.5 Beijing Xinzhida Neural Technology Co., Ltd Recent Developments
7.38 Nanjing Vishee Medical Technology Co., Ltd.
7.38.1 Nanjing Vishee Medical Technology Co., Ltd. Company Information
7.38.2 Nanjing Vishee Medical Technology Co., Ltd. Introduction and Business Overview
7.38.3 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.38.4 Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Offerings
7.38.5 Nanjing Vishee Medical Technology Co., Ltd. Recent Developments
7.39 Xiangyu Medical Co.,Ltd.
7.39.1 Xiangyu Medical Co.,Ltd. Company Information
7.39.2 Xiangyu Medical Co.,Ltd. Introduction and Business Overview
7.39.3 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.39.4 Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Offerings
7.39.5 Xiangyu Medical Co.,Ltd. Recent Developments
7.40 Jiangsu Apon Medical Technology Co.,Ltd.
7.40.1 Jiangsu Apon Medical Technology Co.,Ltd. Company Information
7.40.2 Jiangsu Apon Medical Technology Co.,Ltd. Introduction and Business Overview
7.40.3 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales, Revenue, Price and Gross Margin (2021–2026)
7.40.4 Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Offerings
7.40.5 Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Brain-computer Interface System Industrial Chain
8.2 Brain-computer Interface System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Brain-computer Interface System Sales Model
8.5.2 Sales Channels
8.5.3 Brain-computer Interface System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Brain-computer Interface System Market Trends
Table 2. Brain-computer Interface System Market Drivers & Opportunities
Table 3. Brain-computer Interface System Market Challenges
Table 4. Brain-computer Interface System Market Restraints
Table 5. Global Brain-computer Interface System Revenue by Company (US$ Million), 2021–2026
Table 6. Global Brain-computer Interface System Revenue Market Share by Company (2021–2026)
Table 7. Global Brain-computer Interface System Sales Volume by Company (K Units), 2021–2026
Table 8. Global Brain-computer Interface System Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Brain-computer Interface System Price by Company (K US$/Unit), 2021–2026
Table 10. Key Manufacturers Brain-computer Interface System Manufacturing Base and Headquarters
Table 11. Key Manufacturers Brain-computer Interface System Product Type
Table 12. Key Manufacturers Start of Mass Production of Brain-computer Interface System
Table 13. Global Brain-computer Interface System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Brain-computer Interface System revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Brain-computer Interface System Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Brain-computer Interface System Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Brain-computer Interface System Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Brain-computer Interface System Sales Market Share in Value by Type (2021–2026)
Table 20. Global Brain-computer Interface System Sales Market Share in Value by Type (2027–2032)
Table 21. Global Brain-computer Interface System Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Brain-computer Interface System Sales Volume by Type (K Units), 2021–2026
Table 23. Global Brain-computer Interface System Sales Volume by Type (K Units), 2027–2032
Table 24. Global Brain-computer Interface System Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Brain-computer Interface System Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Brain-computer Interface System Price by Type (K US$/Unit), 2021–2026
Table 27. Global Brain-computer Interface System Price by Type (K US$/Unit), 2027–2032
Table 28. Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count (US$ Million), 2021–2026
Table 30. Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count (US$ Million), 2027–2032
Table 31. Global Brain-computer Interface System Sales Market Share in Value by Signal Acquisition Channel Count (2021–2026)
Table 32. Global Brain-computer Interface System Sales Market Share in Value by Signal Acquisition Channel Count (2027–2032)
Table 33. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (K Units), 2021–2026
Table 35. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (K Units), 2027–2032
Table 36. Global Brain-computer Interface System Sales Market Share in Volume by Signal Acquisition Channel Count (2021–2026)
Table 37. Global Brain-computer Interface System Sales Market Share in Volume by Signal Acquisition Channel Count (2027–2032)
Table 38. Global Brain-computer Interface System Price by Signal Acquisition Channel Count (K US$/Unit), 2021–2026
Table 39. Global Brain-computer Interface System Price by Signal Acquisition Channel Count (K US$/Unit), 2027–2032
Table 40. Global Brain-computer Interface System Sales Value by Primary Signal Modality: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Global Brain-computer Interface System Sales Value by Primary Signal Modality (US$ Million), 2021–2026
Table 42. Global Brain-computer Interface System Sales Value by Primary Signal Modality (US$ Million), 2027–2032
Table 43. Global Brain-computer Interface System Sales Market Share in Value by Primary Signal Modality (2021–2026)
Table 44. Global Brain-computer Interface System Sales Market Share in Value by Primary Signal Modality (2027–2032)
Table 45. Global Brain-computer Interface System Sales Volume by Primary Signal Modality: 2021 vs 2025 vs 2032 (K Units)
Table 46. Global Brain-computer Interface System Sales Volume by Primary Signal Modality (K Units), 2021–2026
Table 47. Global Brain-computer Interface System Sales Volume by Primary Signal Modality (K Units), 2027–2032
Table 48. Global Brain-computer Interface System Sales Market Share in Volume by Primary Signal Modality (2021–2026)
Table 49. Global Brain-computer Interface System Sales Market Share in Volume by Primary Signal Modality (2027–2032)
Table 50. Global Brain-computer Interface System Price by Primary Signal Modality (K US$/Unit), 2021–2026
Table 51. Global Brain-computer Interface System Price by Primary Signal Modality (K US$/Unit), 2027–2032
Table 52. Global Brain-computer Interface System Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Global Brain-computer Interface System Sales Value by Application (US$ Million), 2021–2026
Table 54. Global Brain-computer Interface System Sales Value by Application (US$ Million), 2027–2032
Table 55. Global Brain-computer Interface System Sales Market Share in Value by Application (2021–2026)
Table 56. Global Brain-computer Interface System Sales Market Share in Value by Application (2027–2032)
Table 57. Global Brain-computer Interface System Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 58. Global Brain-computer Interface System Sales Volume by Application (K Units), 2021–2026
Table 59. Global Brain-computer Interface System Sales Volume by Application (K Units), 2027–2032
Table 60. Global Brain-computer Interface System Sales Market Share in Volume by Application (2021–2026)
Table 61. Global Brain-computer Interface System Sales Market Share in Volume by Application (2027–2032)
Table 62. Global Brain-computer Interface System Price by Application (K US$/Unit), 2021–2026
Table 63. Global Brain-computer Interface System Price by Application (K US$/Unit), 2027–2032
Table 64. Global Brain-computer Interface System Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 65. Global Brain-computer Interface System Sales Value by Region (US$ Million), 2021–2026
Table 66. Global Brain-computer Interface System Sales Value by Region (US$ Million), 2027–2032
Table 67. Global Brain-computer Interface System Sales Value by Region (%), 2021–2026
Table 68. Global Brain-computer Interface System Sales Value by Region (%), 2027–2032
Table 69. Global Brain-computer Interface System Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 70. Global Brain-computer Interface System Sales Volume by Region (K Units), 2021–2026
Table 71. Global Brain-computer Interface System Sales Volume by Region (K Units), 2027–2032
Table 72. Global Brain-computer Interface System Sales Volume by Region (%), 2021–2026
Table 73. Global Brain-computer Interface System Sales Volume by Region (%), 2027–2032
Table 74. Global Brain-computer Interface System Average Price by Region (K US$/Unit), 2021–2026
Table 75. Global Brain-computer Interface System Average Price by Region (K US$/Unit), 2027–2032
Table 76. Key Countries/Regions Brain-computer Interface System Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 77. Key Countries/Regions Brain-computer Interface System Sales Value, (US$ Million), 2021–2026
Table 78. Key Countries/Regions Brain-computer Interface System Sales Value, (US$ Million), 2027–2032
Table 79. Key Countries/Regions Brain-computer Interface System Sales Volume, (K Units), 2021–2026
Table 80. Key Countries/Regions Brain-computer Interface System Sales Volume, (K Units), 2027–2032
Table 81. Neuralink Company Information
Table 82. Neuralink Introduction and Business Overview
Table 83. Neuralink Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 84. Neuralink Brain-computer Interface System Product Offerings
Table 85. Neuralink Recent Developments
Table 86. OpenBCI Company Information
Table 87. OpenBCI Introduction and Business Overview
Table 88. OpenBCI Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 89. OpenBCI Brain-computer Interface System Product Offerings
Table 90. OpenBCI Recent Developments
Table 91. NeuroPace Company Information
Table 92. NeuroPace Introduction and Business Overview
Table 93. NeuroPace Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 94. NeuroPace Brain-computer Interface System Product Offerings
Table 95. NeuroPace Recent Developments
Table 96. Emotiv Company Information
Table 97. Emotiv Introduction and Business Overview
Table 98. Emotiv Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 99. Emotiv Brain-computer Interface System Product Offerings
Table 100. Emotiv Recent Developments
Table 101. NeuroSky Company Information
Table 102. NeuroSky Introduction and Business Overview
Table 103. NeuroSky Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 104. NeuroSky Brain-computer Interface System Product Offerings
Table 105. NeuroSky Recent Developments
Table 106. ANT Neuro Company Information
Table 107. ANT Neuro Introduction and Business Overview
Table 108. ANT Neuro Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 109. ANT Neuro Brain-computer Interface System Product Offerings
Table 110. ANT Neuro Recent Developments
Table 111. Blackrock Neurotech Company Information
Table 112. Blackrock Neurotech Introduction and Business Overview
Table 113. Blackrock Neurotech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 114. Blackrock Neurotech Brain-computer Interface System Product Offerings
Table 115. Blackrock Neurotech Recent Developments
Table 116. Synchron Company Information
Table 117. Synchron Introduction and Business Overview
Table 118. Synchron Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 119. Synchron Brain-computer Interface System Product Offerings
Table 120. Synchron Recent Developments
Table 121. g.tec medical engineering GmbH Company Information
Table 122. g.tec medical engineering GmbH Introduction and Business Overview
Table 123. g.tec medical engineering GmbH Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 124. g.tec medical engineering GmbH Brain-computer Interface System Product Offerings
Table 125. g.tec medical engineering GmbH Recent Developments
Table 126. Brain Products Company Information
Table 127. Brain Products Introduction and Business Overview
Table 128. Brain Products Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 129. Brain Products Brain-computer Interface System Product Offerings
Table 130. Brain Products Recent Developments
Table 131. Bitbrain Company Information
Table 132. Bitbrain Introduction and Business Overview
Table 133. Bitbrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 134. Bitbrain Brain-computer Interface System Product Offerings
Table 135. Bitbrain Recent Developments
Table 136. Precision Neuroscience Company Information
Table 137. Precision Neuroscience Introduction and Business Overview
Table 138. Precision Neuroscience Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 139. Precision Neuroscience Brain-computer Interface System Product Offerings
Table 140. Precision Neuroscience Recent Developments
Table 141. Paradromics Company Information
Table 142. Paradromics Introduction and Business Overview
Table 143. Paradromics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 144. Paradromics Brain-computer Interface System Product Offerings
Table 145. Paradromics Recent Developments
Table 146. InteraXon Company Information
Table 147. InteraXon Introduction and Business Overview
Table 148. InteraXon Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 149. InteraXon Brain-computer Interface System Product Offerings
Table 150. InteraXon Recent Developments
Table 151. Neurable Company Information
Table 152. Neurable Introduction and Business Overview
Table 153. Neurable Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 154. Neurable Brain-computer Interface System Product Offerings
Table 155. Neurable Recent Developments
Table 156. Mentalab Company Information
Table 157. Mentalab Introduction and Business Overview
Table 158. Mentalab Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 159. Mentalab Brain-computer Interface System Product Offerings
Table 160. Mentalab Recent Developments
Table 161. mBrainTrain Company Information
Table 162. mBrainTrain Introduction and Business Overview
Table 163. mBrainTrain Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 164. mBrainTrain Brain-computer Interface System Product Offerings
Table 165. mBrainTrain Recent Developments
Table 166. Neuroelectrics Company Information
Table 167. Neuroelectrics Introduction and Business Overview
Table 168. Neuroelectrics Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 169. Neuroelectrics Brain-computer Interface System Product Offerings
Table 170. Neuroelectrics Recent Developments
Table 171. CGX Systems (formerly Cognionics) Company Information
Table 172. CGX Systems (formerly Cognionics) Introduction and Business Overview
Table 173. CGX Systems (formerly Cognionics) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 174. CGX Systems (formerly Cognionics) Brain-computer Interface System Product Offerings
Table 175. CGX Systems (formerly Cognionics) Recent Developments
Table 176. Neurosity Company Information
Table 177. Neurosity Introduction and Business Overview
Table 178. Neurosity Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 179. Neurosity Brain-computer Interface System Product Offerings
Table 180. Neurosity Recent Developments
Table 181. Wearable Sensing Company Information
Table 182. Wearable Sensing Introduction and Business Overview
Table 183. Wearable Sensing Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 184. Wearable Sensing Brain-computer Interface System Product Offerings
Table 185. Wearable Sensing Recent Developments
Table 186. Compumedics Neuroscan Company Information
Table 187. Compumedics Neuroscan Introduction and Business Overview
Table 188. Compumedics Neuroscan Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 189. Compumedics Neuroscan Brain-computer Interface System Product Offerings
Table 190. Compumedics Neuroscan Recent Developments
Table 191. SmartCap(Wenco) Company Information
Table 192. SmartCap(Wenco) Introduction and Business Overview
Table 193. SmartCap(Wenco) Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 194. SmartCap(Wenco) Brain-computer Interface System Product Offerings
Table 195. SmartCap(Wenco) Recent Developments
Table 196. Shimadzu Company Information
Table 197. Shimadzu Introduction and Business Overview
Table 198. Shimadzu Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 199. Shimadzu Brain-computer Interface System Product Offerings
Table 200. Shimadzu Recent Developments
Table 201. BrainCo Company Information
Table 202. BrainCo Introduction and Business Overview
Table 203. BrainCo Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 204. BrainCo Brain-computer Interface System Product Offerings
Table 205. BrainCo Recent Developments
Table 206. Neuracle Technology Company Information
Table 207. Neuracle Technology Introduction and Business Overview
Table 208. Neuracle Technology Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 209. Neuracle Technology Brain-computer Interface System Product Offerings
Table 210. Neuracle Technology Recent Developments
Table 211. CUSOFT Company Information
Table 212. CUSOFT Introduction and Business Overview
Table 213. CUSOFT Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 214. CUSOFT Brain-computer Interface System Product Offerings
Table 215. CUSOFT Recent Developments
Table 216. Deayea Company Information
Table 217. Deayea Introduction and Business Overview
Table 218. Deayea Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 219. Deayea Brain-computer Interface System Product Offerings
Table 220. Deayea Recent Developments
Table 221. Entertech Company Information
Table 222. Entertech Introduction and Business Overview
Table 223. Entertech Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 224. Entertech Brain-computer Interface System Product Offerings
Table 225. Entertech Recent Developments
Table 226. HNNK Company Information
Table 227. HNNK Introduction and Business Overview
Table 228. HNNK Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 229. HNNK Brain-computer Interface System Product Offerings
Table 230. HNNK Recent Developments
Table 231. StairMed Company Information
Table 232. StairMed Introduction and Business Overview
Table 233. StairMed Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 234. StairMed Brain-computer Interface System Product Offerings
Table 235. StairMed Recent Developments
Table 236. NeuroXess Company Information
Table 237. NeuroXess Introduction and Business Overview
Table 238. NeuroXess Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 239. NeuroXess Brain-computer Interface System Product Offerings
Table 240. NeuroXess Recent Developments
Table 241. Enlight Medical Company Information
Table 242. Enlight Medical Introduction and Business Overview
Table 243. Enlight Medical Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 244. Enlight Medical Brain-computer Interface System Product Offerings
Table 245. Enlight Medical Recent Developments
Table 246. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Company Information
Table 247. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Introduction and Business Overview
Table 248. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 249. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Brain-computer Interface System Product Offerings
Table 250. Tiankai Suishi (Tianjin) Intelligent Technology Co., Ltd. Recent Developments
Table 251. Hanix Company Information
Table 252. Hanix Introduction and Business Overview
Table 253. Hanix Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 254. Hanix Brain-computer Interface System Product Offerings
Table 255. Hanix Recent Developments
Table 256. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Company Information
Table 257. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Introduction and Business Overview
Table 258. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 259. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Brain-computer Interface System Product Offerings
Table 260. Zhongdian Yunnao (Tianjin) Technology Co., Ltd. Recent Developments
Table 261. Beijing Xinzhida Neural Technology Co., Ltd Company Information
Table 262. Beijing Xinzhida Neural Technology Co., Ltd Introduction and Business Overview
Table 263. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 264. Beijing Xinzhida Neural Technology Co., Ltd Brain-computer Interface System Product Offerings
Table 265. Beijing Xinzhida Neural Technology Co., Ltd Recent Developments
Table 266. Nanjing Vishee Medical Technology Co., Ltd. Company Information
Table 267. Nanjing Vishee Medical Technology Co., Ltd. Introduction and Business Overview
Table 268. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 269. Nanjing Vishee Medical Technology Co., Ltd. Brain-computer Interface System Product Offerings
Table 270. Nanjing Vishee Medical Technology Co., Ltd. Recent Developments
Table 271. Xiangyu Medical Co.,Ltd. Company Information
Table 272. Xiangyu Medical Co.,Ltd. Introduction and Business Overview
Table 273. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 274. Xiangyu Medical Co.,Ltd. Brain-computer Interface System Product Offerings
Table 275. Xiangyu Medical Co.,Ltd. Recent Developments
Table 276. Jiangsu Apon Medical Technology Co.,Ltd. Company Information
Table 277. Jiangsu Apon Medical Technology Co.,Ltd. Introduction and Business Overview
Table 278. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 279. Jiangsu Apon Medical Technology Co.,Ltd. Brain-computer Interface System Product Offerings
Table 280. Jiangsu Apon Medical Technology Co.,Ltd. Recent Developments
Table 281. Key Raw Materials Lists
Table 282. Key Suppliers of Raw Materials Lists
Table 283. Brain-computer Interface System Downstream Customers
Table 284. Brain-computer Interface System Distributors List
Table 285. Research Programs/Design for This Report
Table 286. Key Data Information from Secondary Sources
Table 287. Key Data Information from Primary Sources
List of Figures
Figure 1. Brain-computer Interface System Product Picture
Figure 2. Global Brain-computer Interface System Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 4. Global Brain-computer Interface System Sales Volume (K Units), 2021–2032
Figure 5. Global Brain-computer Interface System Sales Price (K US$/Unit), 2021–2032
Figure 6. Brain-computer Interface System Report Years Considered
Figure 7. Global Brain-computer Interface System Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Brain-computer Interface System Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brain-computer Interface System Revenue in 2025
Figure 10. Brain-computer Interface System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Non-Invasive Picture
Figure 12. Partially Invasive Picture
Figure 13. Invasive Picture
Figure 14. Global Brain-computer Interface System Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Brain-computer Interface System Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Brain-computer Interface System Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 17. Global Brain-computer Interface System Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Brain-computer Interface System Price by Type (K US$/Unit), 2021–2032
Figure 19. 1 To 8 Channels Picture
Figure 20. 9 To 32 Channels Picture
Figure 21. 33 To 128 Channels Picture
Figure 22. 128 To 256 Channels Picture
Figure 23. Global Brain-computer Interface System Sales Value by Signal Acquisition Channel Count (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Brain-computer Interface System Sales Value Market Share by Signal Acquisition Channel Count, 2025 & 2032
Figure 25. Global Brain-computer Interface System Sales Volume by Signal Acquisition Channel Count (K Units), 2021 vs 2025 vs 2032
Figure 26. Global Brain-computer Interface System Sales Volume Market Share by Signal Acquisition Channel Count, 2025 & 2032
Figure 27. Global Brain-computer Interface System Price by Signal Acquisition Channel Count (K US$/Unit), 2021–2032
Figure 28. EEG Picture
Figure 29. ECoG Picture
Figure 30. Spikes & LFPs Picture
Figure 31. fNIRS, MEG and Others Picture
Figure 32. Global Brain-computer Interface System Sales Value by Primary Signal Modality (US$ Million), 2021 vs 2025 vs 2032
Figure 33. Global Brain-computer Interface System Sales Value Market Share by Primary Signal Modality, 2025 & 2032
Figure 34. Global Brain-computer Interface System Sales Volume by Primary Signal Modality (K Units), 2021 vs 2025 vs 2032
Figure 35. Global Brain-computer Interface System Sales Volume Market Share by Primary Signal Modality, 2025 & 2032
Figure 36. Global Brain-computer Interface System Price by Primary Signal Modality (K US$/Unit), 2021–2032
Figure 37. Product Picture of Medical Rehabilitation
Figure 38. Product Picture of Daily Life and Entertainment Consumption
Figure 39. Product Picture of Industrial Control
Figure 40. Product Picture of Traffic Driving
Figure 41. Product Picture of Research & Education
Figure 42. Product Picture of Military and Others
Figure 43. Global Brain-computer Interface System Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 44. Global Brain-computer Interface System Sales Value Market Share by Application, 2025 & 2032
Figure 45. Global Brain-computer Interface System Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 46. Global Brain-computer Interface System Sales Volume Market Share by Application, 2025 & 2032
Figure 47. Global Brain-computer Interface System Price by Application (K US$/Unit), 2021–2032
Figure 48. North America Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 49. North America Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
Figure 50. Europe Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 51. Europe Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
Figure 52. Asia Pacific Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 53. Asia Pacific Brain-computer Interface System Sales Value by Region (%), 2025 vs 2032
Figure 54. South America Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 55. South America Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
Figure 56. Middle East & Africa Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 57. Middle East & Africa Brain-computer Interface System Sales Value by Country (%), 2025 vs 2032
Figure 58. Key Countries/Regions Brain-computer Interface System Sales Value (%), 2021–2032
Figure 59. Key Countries/Regions Brain-computer Interface System Sales Volume (%), 2021–2032
Figure 60. United States Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 61. United States Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 62. United States Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 63. Europe Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 64. Europe Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 65. Europe Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 66. China Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 67. China Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 68. China Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 69. Japan Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 70. Japan Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 71. Japan Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 72. South Korea Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 73. South Korea Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 74. South Korea Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 75. Southeast Asia Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 76. Southeast Asia Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 77. Southeast Asia Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 78. India Brain-computer Interface System Sales Value (US$ Million), 2021–2032
Figure 79. India Brain-computer Interface System Sales Value by Type (%), 2025 vs 2032
Figure 80. India Brain-computer Interface System Sales Value by Application (%), 2025 vs 2032
Figure 81. Brain-computer Interface System Industrial Chain
Figure 82. Brain-computer Interface System Manufacturing Cost Structure
Figure 83. Channels of Distribution (Direct Sales, and Distribution)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Brain-computer Interface System in 2026?
The global market size of Brain-computer Interface System in 2026 was 972 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Brain-computer Interface System market size from 2026 to 2032?
Which companies rank high in the global Brain-computer Interface System market?
What was the global market size of Brain-computer Interface System in 2032?
Related Reports
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-26
Pages: 228
USD 4900.00
(Single User License)
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Brain-computer Interface System market size was US$ 836 million in 2025 and is forecast to reach a readjusted size of US$ 2962 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published Date: 2026-07-26
Pages: 195
USD 4250.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2026
The global Brain-computer Interface System market was valued at US$ 836 million in 2025 and is anticipated to reach US$ 2962 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-07-26
Pages: 161
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 134
USD 4900.00
(Single User License)
Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 96
USD 4250.00
(Single User License)
Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 113
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published Date: 2024-04-08
Pages: 114
USD 4900.00
(Single User License)
Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 106
USD 3950.00
(Single User License)
Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 83
USD 2900.00
(Single User License)
Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Brain-computer Interface System market is projected to grow from US$ 836 million in 2025 to US$ 2962 million by 2032, at a CAGR of 20.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-26
Pages: 228
USD 4900.00 (Single User License)Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Brain-computer Interface System market size was US$ 836 million in 2025 and is forecast to reach a readjusted size of US$ 2962 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published: 2026-07-26
Pages: 195
USD 4250.00 (Single User License)Global Brain-computer Interface System Market Research Report 2026
The global Brain-computer Interface System market was valued at US$ 836 million in 2025 and is anticipated to reach US$ 2962 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-07-26
Pages: 161
USD 2900.00 (Single User License)Global Brain-computer Interface System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Brain-computer Interface System market is projected to grow from US$ 186 million in 2024 to US$ 223 million by 2031, at a CAGR of 2.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 134
USD 4900.00 (Single User License)Global Brain-computer Interface System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain-computer Interface System market size was US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 96
USD 4250.00 (Single User License)Brain-computer Interface System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain-computer Interface System was estimated to be worth US$ 186 million in 2024 and is forecast to a readjusted size of US$ 223 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 113
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2025
The global market for Brain-computer Interface System was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Published: 2025-02-20
Pages: 88
USD 2900.00 (Single User License)Global Brain-computer Interface System Market Insights, Forecast to 2030
Market Analysis and Insights: Global Brain-computer Interface System Market
Published: 2024-04-08
Pages: 114
USD 4900.00 (Single User License)Brain-computer Interface System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Brain-computer Interface System was estimated to be worth US$ 177 million in 2023 and is forecast to a readjusted size of US$ 212.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 106
USD 3950.00 (Single User License)Global Brain-computer Interface System Market Research Report 2024
The global Brain-computer Interface System market was valued at US$ 177 million in 2023 and is anticipated to reach US$ 212.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
COMPETITIVE LANDSCAPE ANALYSIS
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now